← Back to Search

Decision Support Tool for Peripheral Arterial Disease

N/A

Recruiting

Led By Kim G Smolderen, PhD

Research Sponsored by Saint Luke's Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

New onset complaints of PAD symptoms or exacerbation of previous PAD symptoms

Age ≥18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial aims to improve care for patients with PAD by making evidence on treatment outcomes more transparently available to patients and providers, such that more informed, evidence-based shared treatment decisions occur.

Who is the study for?

The SHOWME-PAD trial is for English-speaking men and women over 18 with Peripheral Arterial Disease (PAD), diagnosed through tests like Doppler ABI, Duplex, CTA, MRA, TCOM or Angiogram. It's not for those who can't consent, don't speak English, have had certain leg procedures in the past year or are currently experiencing severe PAD symptoms.Check my eligibility

What is being tested?

This trial is testing a Decision Support Tool designed to help patients with PAD and their providers make better-informed treatment decisions by providing clear information on health outcomes from the patient's perspective.See study design

What are the potential side effects?

Since this trial involves a decision support tool rather than medication or invasive treatments, traditional physical side effects are not expected. However, there may be psychological impacts from learning about disease outcomes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have new or worsening symptoms of leg pain when walking.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decisional Conflict

Trial Design

1Treatment groups

Experimental Treatment

Group I: Received Decision ToolExperimental Treatment1 Intervention

Peripheral artery disease patients that received the decision support tool.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Merck Sharp & Dohme LLCIndustry Sponsor

3,888 Previous Clinical Trials

5,055,011 Total Patients Enrolled

8 Trials studying Peripheral Arterial Disease

52,612 Patients Enrolled for Peripheral Arterial Disease

Saint Luke's Health SystemLead Sponsor

41 Previous Clinical Trials

12,874 Total Patients Enrolled

2 Trials studying Peripheral Arterial Disease

1,613 Patients Enrolled for Peripheral Arterial Disease

Kim G Smolderen, PhDPrincipal InvestigatorUniversity of Missouri Kansas City; Saint Luke's Hospital

Media Library

Decision Support Tool Clinical Trial Eligibility Overview. Trial Name: NCT03190382 — N/A

Peripheral Arterial Disease Research Study Groups: Received Decision Tool

Peripheral Arterial Disease Clinical Trial 2023: Decision Support Tool Highlights & Side Effects. Trial Name: NCT03190382 — N/A

Decision Support Tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT03190382 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are engaged in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is actively recruiting patients and was initially posted on June 24th 2017, with the most recent update occurring in April 7th 2022. A total of 72 participants are being sought from one location."

Answered by AI

Are there any unfilled opportunities for participants in this experiment?

"As visible on clinicaltrials.gov, the medical trial is presently recruiting patients and was originally posted on June 24th 2017 before being updated lastly on April 7th 2022."

Answered by AI

Recent research and studies

Medical Decision MakingJournal

Validation of a Decisional Conflict Scale

O'Connor, Annette M.. 1995. “Validation of a Decisional Conflict Scale”. Medical Decision Making. SAGE Publications. doi:10.1177/0272989x9501500105.

Annals of Vascular SurgeryJournal

The Impact of Peripheral and Coronary Artery Disease on Health-related Quality of Life

de Graaff, Jurgen C., Dirk Th. Ubbink, Elisabeth (Ilse) J.C. Kools, Steven A.J. Chamuleau, and Michael J.H.M. Jacobs. 2002. “The Impact of Peripheral and Coronary Artery Disease on Health-related Quality of Life”. Annals of Vascular Surgery. Elsevier BV. doi:10.1007/s10016-001-0121-9.

Journal of the American College of CardiologyJournal

2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients with Peripheral Artery Disease (updating the 2005 Guideline)

Rooke, Thom W., Alan T. Hirsch, Sanjay Misra, Anton N. Sidawy, Joshua A. Beckman, Laura K. Findeiss, Jafar Golzarian, et al.. 2011. “2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients with Peripheral Artery Disease (updating the 2005 Guideline)”. Journal of the American College of Cardiology. Elsevier BV. doi:10.1016/j.jacc.2011.08.023.

Vascular MedicineJournal